Literature DB >> 26192610

Terminal restriction fragment polymorphism analyses of fecal microbiota in five siblings including two with ulcerative colitis.

Akira Andoh1, Shinobu Ida2, Tomoyuki Tsujikawa3, Yoshimi Benno4, Yoshihide Fujiyama3.   

Abstract

In the pathophysiology of inflammatory bowel diseases (IBD), interaction between mucosal immune system and commensal enteric bacteria plays an important role. In this study, we performed terminal restriction fragment length polymorphism (T-RFLP) analyses of fecal microbiota from five siblings, which included two subjects with ulcerative colitis (UC). Fecal microbiota in the two siblings with UC were clearly different from those obtained from the healthy siblings. The mother's pattern was a cross between the UC and the healthy siblings. Predicted bacteria based on a BslI-digested T-RFLP database showed a tendency of increases in Clostridium cluster IX and decreases in Clostridium cluster XIVa in the UC siblings. These data indicate that fecal microbial communities differed between UC subjects and healthy individuals under conditions where environmental effects on fecal microbiota may be minimized.

Entities:  

Keywords:  Environment; Inflammatory bowel disease; Microbiota

Year:  2009        PMID: 26192610     DOI: 10.1007/s12328-009-0106-8

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  13 in total

1.  Terminal restriction fragment length polymorphism analysis program, a web-based research tool for microbial community analysis.

Authors:  T L Marsh; P Saxman; J Cole; J Tiedje
Journal:  Appl Environ Microbiol       Date:  2000-08       Impact factor: 4.792

2.  Terminal restriction fragment length polymorphism analysis for human fecal microbiota and its application for analysis of complex bifidobacterial communities.

Authors:  Mitsuo Sakamoto; Hidenori Hayashi; Yoshimi Benno
Journal:  Microbiol Immunol       Date:  2003       Impact factor: 1.955

3.  Application of terminal RFLP analysis to characterize oral bacterial flora in saliva of healthy subjects and patients with periodontitis.

Authors:  Mitsuo Sakamoto; Yasuo Takeuchi; Makoto Umeda; Isao Ishikawa; Yoshimi Benno
Journal:  J Med Microbiol       Date:  2003-01       Impact factor: 2.472

4.  Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces.

Authors:  Koji Nagashima; Takayoshi Hisada; Maremi Sato; Jun Mochizuki
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

Review 5.  Microbial influences in inflammatory bowel diseases.

Authors:  R Balfour Sartor
Journal:  Gastroenterology       Date:  2008-02       Impact factor: 22.682

6.  Faecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis.

Authors:  A Andoh; T Tsujikawa; M Sasaki; K Mitsuyama; Y Suzuki; T Matsui; T Matsumoto; Y Benno; Y Fujiyama
Journal:  Aliment Pharmacol Ther       Date:  2008-09-26       Impact factor: 8.171

7.  Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism.

Authors:  Hidenori Hayashi; Rei Takahashi; Takahiro Nishi; Mitsuo Sakamoto; Yoshimi Benno
Journal:  J Med Microbiol       Date:  2005-11       Impact factor: 2.472

8.  Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

Authors:  Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag
Journal:  J Pediatr       Date:  2005-01       Impact factor: 4.406

9.  Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis.

Authors:  Akira Andoh; Shinji Sakata; Yuhsuke Koizumi; Keiichi Mitsuyama; Yoshihide Fujiyama; Yoshimi Benno
Journal:  Inflamm Bowel Dis       Date:  2007-08       Impact factor: 5.325

10.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

View more
  1 in total

Review 1.  Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease.

Authors:  Laila Aldars-García; María Chaparro; Javier P Gisbert
Journal:  Microorganisms       Date:  2021-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.